Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews

No studies found 1 · 20%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 40%Moderate 2 · 40%High 0 · 0%

Death at the end of treatment · people with acute ischemic stroke

Calcium antagonists showed no clear difference in death at the end of treatment compared with placebo (moderate certainty).

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
RR 1.06 [0.93, 1.2]
22 studies · 6323 participants
Moderate

Death at the end of treatment · people with acute ischemic stroke

Other calcium antagonists showed no clear difference in death at the end of treatment compared with placebo (low certainty).

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
RR 0.98 [0.58, 1.66]
3 studies · 370 participants
Low

Death at the end of treatment · people with acute ischemic stroke

Flunarizine showed no clear difference in death at the end of treatment compared with placebo (low certainty).

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
RR 1.31 [0.94, 1.82]
3 studies · 790 participants
Low

Death at the end of treatment · people with acute ischemic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Death at the end of treatment · people with acute ischemic stroke

Nimodipine showed no clear difference in death at the end of treatment compared with placebo (moderate certainty).

1 finding from 1 review

Calcium antagonists for acute ischemic stroke 2019 · Cochrane Headline outcomes only
RR 1.02 [0.88, 1.19]
16 studies · 5163 participants
Moderate